Grants for Nonprofits - Federal

The Office of Community Oriented Policing Services (COPS Office) is the component of the U.S. Department of Justice responsible for advancing the practice of community policing by the nations state, local, territorial, and tribal law enforcement agencies through information and grant resources. The COPS Office is pleased to announce that it is seeking applications for funding for the FY 24 CPD: Law Enforcement Products and Resources program. Community Policing Development (CPD) funds are used to develop the capacity of law enforcement to implement community policing strategies by providing guidance on promising practices through the development and testing of innovative strategies; building knowledge about effective practices and outcomes; and supporting new, creative approaches to preventing crime and promoting safe communities. FY 2024 Law Enforcement Products and Resources CPD program funding supports the development of law enforcement products and resources specifically designed for national distribution that offer creative ideas to advance crime fighting, community engagement, problem solving, or organizational changes in support of community policing.

This grant provides funding to organizations in Utah to improve broadband access and infrastructure, ensuring more residents can connect to high-speed internet.

Small research (R03) grants provide flexibility for initiating studies which are generally for preliminary or short-term projects. These grants are non-renewable. Some examples of the types of projects that R03 research supports include: Pilot or feasibility studies Secondary analysis of existing data Small, self-contained research projects Development of research methodology Development of new research technology The AHRQ small grant is a mechanism for supporting discrete, well-defined projects that realistically can be completed within two years (or less) within the budget constraints of the mechanism. Because the research strategy section of the application is limited to 6 pages, an R03 grant application may not contain the same level of detail as that found in an R01 application. Accordingly, appropriate justification for the proposed work can be provided through literature citations, data from other sources, or from investigator-generated data. Preliminary data are not required, particularly in applications proposing pilot or feasibility studies. The Small Research Grant (R03) is an award made by AHRQ to an institution/organization to support a discrete health services research project. The R03 research strategy proposed by the applicant institution/organization must be related to the mission and research interests of AHRQ, which are detailed below. Although the PD/PI is responsible for conducting and supervising the research, the actual applicant is the research institution/organization legally accountable for the performance of the award and the expenditure of funds. AHRQ Mission and Research Areas of Interest: The AHRQ mission is to produce evidence to make health care safer, higher quality, more ac­cessible, equitable and affordable, and to work with HHS and other partners to make sure that the evidence is understood and used. Within this mission, AHRQ’s specific priority areas of focus are: Research to improve health care patient safety. Harnessing data and technology to improve health care quality and patient outcomes and to provide a 360-degree view of the patient. Research to increase accessibility and affordability of health care by examining innovative market approaches to care delivery and financing. Research to Improve Health Care Patient Safety Patient safety is defined as the freedom from accidental or preventable injury produced by health care as well as the practices that create a safe environment of care. The ultimate goal of AHRQ-supported Patient Safety research is to improve the safety of health care delivery. Patient safety research initiatives that lead to this goal can be considered in three different stages: Identification of risks, hazards, and patient harm. Design, implementation, dissemination and spread, and evaluation of interventions to improve patient safety. Establishment of strategies to sustain patient safety improvements such as just culture, incident/event reporting, measurement, monitoring, and surveillance. AHRQ's Patient Safety Research Program: (1) identifies specific areas of focus through targeted grant funding announcements (i.e., Program Announcements, Requests for Applications, and Special Emphasis Notices) and (2) encourages investigators to utilize the Agency's general funding announcements to apply this research framework in response to other patient safety threats and opportunities for improvement. The Patient Safety Portfolio will support research projects to create new knowledge by identifying the risks, hazards, and harm encountered by patients as a result of health care. The Portfolio will also support projects that mitigate those risks, hazards, and harm including the design, implementation and evaluation of strategies (patient safety practices) and the adaptation, refinement, and sustainment of those strategies. These initiatives are part of the Agency's overall mission to improve the quality of health care. AHRQ encourages an interdisciplinary, systems science patient safety approach. In addition to health services research, perspectives from organizational theory, human factors, industrial engineering, facilities design, education, and other disciplines can be incorporated in research plans. Projects may address important topics such as: the surveillance, measurement, detection, and reporting of patient safety events; the impact of human performance, work flow, and working conditions on patient safety; the patients' role and contribution to patient safety; health care safety culture, leadership, communication, teamwork, and simulation; prevention and control of healthcare-associated infections (HAIs); diagnostic safety and quality; the safe use of medical devices and medications, including safely prescribing opioids; the role of Patient Safety Organizations; and the challenges inherent in transitions of care in the same setting and between settings and handoffs between health care providers. Research related to the prevention and control of HAIs is an instructive example of AHRQ’s Patient Safety research interests. AHRQ supports research whose short-term or long-term aim is to develop improved methods for preventing HAIs and to develop effective implementation strategies for HAI prevention in all health care settings. Accordingly, AHRQ’s foci of interest in HAI research are the following broad areas: Determination of the clinical efficacy and effectiveness of preventive interventions, including unintended adverse consequences. Characterization and assessment of relevant epidemiological aspects of HAIs, including but not limited to patient risk factors, clinical presentation, and sources of antibiotic-resistant organisms involved in the development of HAIs. Demonstration, dissemination, and evaluation of strategies and approaches for prevention and reduction of HAIs. Research regarding adoption and implementation (including sustainment, spread, and scale-up) of evidence-based approaches for prevention of HAIs. The HAI research portfolio also encompasses generation of knowledge for combating antibiotic resistant bacteria. AHRQ is interested in studies to promote appropriate antibiotic use, reduce the transmission of resistant bacteria, and prevent HAIs in the first place. The last contributes to antibiotic stewardship by avoiding the need for antibiotic therapy and precludes the possibility of a resistant infection. Clinical investigations that seek to establish the efficacy or effectiveness of preventive interventions, as noted above, typically involve a comparison of the intervention in question to routine care or, less frequently, to a placebo (when the latter is ethical). Such clinical studies are included in the scope of AHRQ’s HAI research portfolio. The HAI Portfolio does not fund comparisons of two interventions of known efficacy or effectiveness to determine which is more efficacious or effective. Such studies are comparative effectiveness research, which is more appropriately funded by other funding sources. The Portfolio supports research in all health care settings including the hospital, long-term care, ambulatory care, home health care, pharmacy, and transitions of care between settings. Patient safety research involves many stakeholder groups including patients, families, clinicians, non-clinical health care staff, policymakers, payers, and health care organizations including providers and accreditors, local and State governments, and the Federal Government, Patient Safety Organizations, and many others. Projects in this area may also address patient characteristics that might influence the risk of experiencing a patient safety event, for example, attributes of AHRQ's priority populations that can impact patient safety and address strategies to address barriers to safe care. Harnessing Data and Technology To Improve Health Care Quality and Patient Outcomes and To Provide a 360-Degree View of the Patient AHRQ is interested in research to: advance the methods of evidence synthesis to ensure scientific rigor and unbiased reviews, make evidence-based recommendations on clinical preventive services, conduct research on how health information technology can improve the quality of health care, advance the science of clinical practice improvement, evaluate and support innovative models of practice transformation in primary care and other ambulatory settings, and facilitate communities of learning to promote the implementation of evidence for practice improvement. Further, AHRQ is interested in studying and improving upon the process by which health systems and ambulatory care practices select evidence to implement and how to determine what strategies are used to implement the evidence into everyday practice. The study of implementation strategies and processes is critical because interventions developed in the context of publically funded efficacy and effectiveness trials are rarely scalable without adaptations to specific settings and additional tools and guidance to support uptake and implementation. AHRQ is also interested in research that advances whole-person, 360-degree care especially those with multiple chronic conditions and/or socioeconomic disadvantage. Whole person, 360-degree care is defined as the coordination of health, behavioral health, intellectual/developmental disabilities, and social services in a person-centered manner with the goals of improved health outcomes and more efficient and effective use of resources in the context of people’s lives and the communities they live in. Emphasis is on the orientation of the health care team to consider all domains of a person’s life when assessing and addressing needs. The following lists examples of AHRQ research priorities: Improving health care quality outcomes by providing integrated, coordinated whole-person, 360-degree care to optimize individual and population health outcomes: Generation of knowledge about how clinical teams can most effectively elicit and use a patient’s values; preferences; and personal, social, and clinical context to formulate and use plans of care in partnership with patients, caregivers, and families. Preferences, values, and context may be specific to the situation and also can change over time. Therefore, proposals that address how the process of care planning and the care plans themselves will identify and respond to the specific and dynamic nature of patients’ circumstances are of interest. Development of information and data to create/foster/support partnerships and linkages between health care and human service systems (community-based organizations and public health) to improve whole-person care. These could be focused on improving care coordination and strengthening care transitions, ensuring that care is fully integrated to support the whole person and family. Improvement of health care quality through the use of information systems and data resources that both provide meaningful clinical decision support to health care professionals and patients and families at the point of care and that capture important actions and outcomes of health care to increase evidence on effective practices and support clinical and organizational improvement. Implementation of clinical prevention guidelines into learning health systems with innovative ways to include patients’ preferences and values in order to empower whole person-centered care. Development and study of models of shared decision making that are tailored to the needs of disadvantaged populations. Development of whole-person care research to improve health and health services efforts in persons with multiple chronic conditions. Development, implementation, and evaluation of models of primary care for individuals with complexity, including multiple chronic conditions, disability, and socioeconomic disadvantage that improve individual and population health while reducing disparities. Implement research findings in order to accelerate the spread of evidence-based practices by: Implementation of evidence-based approaches to identify, understand, and overcome barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based interventions, tools, policies, and guidelines. Research on de-implementation of the use of health system procedures and clinical practices that are ineffective, have been prematurely widely adopted, or are harmful or wasteful. Development of a parsimonious set of meaningful measures to evaluate implementation and impact of whole-person care. Development of innovative ways to use data and health information technology (IT) in primary care practices in order to increase uptake and implementation of preventive services, especially those involving behavioral change (e.g. obesity prevention, substance use prevention). Development of methods underlying the fields of evidence synthesis, stakeholder and patient engagement, decision making, and practice improvement. Accelerating the ability of health care organizations to evolve as learning health systems that effectively apply data and evidence to improve patient outcomes by: Synthesizing, translating, and communicating complex scientific evidence to facilitate informed care planning and health care decision making by patients, families, and health care professionals at the individual level and informed policy decision making at the health system and population level. Discovering, testing, and spreading methods and strategies for health care practice improvement to improve health care quality, including accelerating the sustainable implementation of evidence-based practice. AHRQ has particular interest in practice improvement in primary care and ambulatory settings. Demonstrating the effectiveness of synthesizing, translating, and communicating complex scientific evidence to facilitate informed care planning and health care decision making by patients, families, and health care professionals at the individual level and informed policy decision making at the health system and population level. Research to Increase Accessibility and Affordability of Health Care by Examining Innovative Market Approaches to Care Delivery and Financing Producing evidence that can be used to increase the affordability and efficiency of health care for all Americans is a major AHRQ priority. Potential research areas and questions include but are not limited to the following: Reducing Cost Growth: In order to make health care more affordable, we must understand the drivers of those costs and their growth, as well as the relationship between cost and quality. Comparing Performance of Systems and Providers: AHRQ is interested in research that will allow comparison of delivery system and provider performance by health care stakeholders such as consumers, providers, payers, insurers, and policymakers. Incentives for Improving Performance: Public and private payers have provided a variety of financial and nonfinancial incentives to improve the performance of health care providers and systems. AHRQ is interested in research on the impacts of these changes—both intended and otherwise—as well as how to improve incentive programs. Interventions to Improve Performance: While alignment with external incentives is very important, it is the provider or system that implements interventions to increase performance. AHRQ is interested in research on how interventions to improve quality or cost are best implemented within and spread across providers and systems.

The NIH INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Project seeks to improve health and quality-of-life for individuals with Down syndrome. This Funding Opportunity Announcement (FOA) invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in Down syndrome. This initiative seeks applications that are intended to facilitate Down syndrome research by enabling efficient and effective movement of candidate therapeutics or diagnostics towards clinical trials for Down syndrome and its co-occurring conditions, and to increase their likelihood of success through development and testing of biomarkers and clinical outcome assessment measures, development and testing of novel trial methods and recruitment strategies, or by defining the presentation and course of the co-occurring conditions in individuals with Down syndrome to enable the design of future clinical trials.

This is a special notice to provide information about the upcoming Notice of Funding Opportunity to establish APEX Accelerators in Fiscal Year 2025. The Procurement Technical Assistance Program (PTAP) was established by section 1241 of the Department of Defense (DoD) Authorization Act for Fiscal Year 1985 (Public Law 98-525) to expand the number of businesses capable of participating in government contracts. Under this announcement, the Department of Defense will award cost sharing cooperative agreements to eligible program participants who will establish or maintain APEX Accelerators. The APEX Accelerators serve as a resource for businesses to obtain information and training related to contracting opportunities with DoD, other federal agencies, state and local governments and with government prime contractors. Procurement professionals at the APEX Accelerators provide critical assistance to businesses seeking to participate in government contracts and most of the assistance they provide is free. B. Program Description/Objective: Award recipients must establish and maintain an APEX Accelerator with physical location(s) to serve as a resource for large and small businesses to obtain procurement technical assistance. Procurement technical assistance means professional, specialized assistance provided to clients that enables them to identify potential contractual opportunities and obtain or perform under contracts, innovation and technology grants, and other DoD-funded instruments, with DoD, other Federal agencies, State and/or local governments, and with Federal, State and/or local government contractors. Clients may include any business pursuing or performing these types of contracts or subcontracts at any tier. As used in this part, the terms “State” and “local government” have the meanings provided in 10 U.S.C. 4951. Innovation and technology grants refer to awards issued pursuant to the Small Business Innovation Research and/or Small Business Technology Transfer programs. You must collaborate with DoD and other Federal agencies and work cooperatively with them to accomplish the work under this award.

The FY2025 Weather Program Office Research Programs Announcement - Air Quality Research and Forecasting (AQRF) aims to enhance the nation's air quality prediction capabilities through innovative research and technology development, with a focus on improving emissions modeling, atmospheric composition predictions, and computational efficiency.

This funding opportunity provides financial support to exceptional clinician scientists who contribute to the development and implementation of NCI clinical trials, ensuring their continued involvement in cancer research without being principal investigators on research project grants.

This grant provides funding for research on how HIV and substance use affect placental health and maternal outcomes, targeting a wide range of institutions and researchers focused on these critical health issues.

This grant provides funding for research projects that explore how sex hormones affect HIV progression and substance use disorders, aiming to develop new therapeutic strategies for these interconnected health issues.

An Ideas Lab is an intensive meeting that brings together multiple diverse perspectives to focus on finding innovative cross-disciplinary solutions to a grand challenge problem (see below and PAPPG Chapter II.F.6. for more information about this type of proposal). The goal of the Personalized Engineering Learning Ideas Lab is to extend engineering education research to enable advanced personalization in pedagogy and assessment in a K-12 or higher education context. The following broad areas have been identified as possible avenues to advance knowledge: personalized engineering education, multimodal sensing for personalized learning systems and team-based personalized learning. This Ideas Lab aims to bring together experts from diverse scientific, engineering and education backgrounds to develop innovative technologies and solutions to achieve personalized learning for engineering education. This Ideas Lab is organized by the Office of Emerging Frontiers and Multidisciplinary Activities (EFMA), the Division of Engineering Education and Centers (EEC), and the Division of Civil, Mechanical and Manufacturing Innovation in the Directorate for Engineering (ENG); the Division of Information and Intelligent Systems (IIS) in the Directorate for Computer and Information Science and Engineering (CISE); the Division of Behavioral and Cognitive Sciences in the Directorate for Social, Behavioral and Economic Sciences (SBE); the Division of Graduate Education, the Division of Research on Learning in Formal and Informal Settings, and the Division of Undergraduate Education in the Directorate for STEM Education (EDU); and the Division of Translational Impacts in the Directorate for Technology, Innovation and Partnerships (TIP). INFORMATIONAL WEBINAR: The Emerging Frontiers and Multidisciplinary Activities (EFMA) Office will host an informational webinar in October 2023 to discuss the Ideas Lab: Personalized Engineering Learningsolicitationandtoanswer questions. Details on how to join this webinar will be posted on the EFMA Website.

This funding opportunity supports research projects that develop and test innovative strategies to improve cancer screening and preventive services for populations facing health disparities, such as racial and ethnic minorities, low-income groups, and rural communities.

The Administration for Children and Families (ACF), Office of Head Start (OHS) announces the availability of approximately $102 million to be competitively awarded for the purpose of expanding access to high-quality, comprehensive services to low-income infants, toddlers, and their families through Early Head Start-Child Care (EHS-CC) Partnerships, or through the expansion of Early Head Start services. ACF solicits applications from public entities, including states, or private non-profit organizations, including community-based or faith-based organizations, or for-profit agencies that meet eligibility for applying as stated in section 42 U.S.C. 9840A of the Head Start Act. Interested applicants may email [email protected] for additional information.OHS encourages interested applicants to visit https://www.acf.hhs.gov/grants/how-apply-grant. This webpage provides information on applying for grants, registering and applying through Grants.gov, submitting an application, and understanding the grant review process.

The "Fiscal Year 2024 Tribal Wetland Program Development Grants" aim to assist tribal governments and intertribal consortia in developing or refining programs that protect, manage, and restore wetlands, with a focus on increasing wetland quantity and quality, and incorporating climate change and environmental justice considerations.

This funding opportunity provides financial support to various organizations and entities to develop training and assistance programs aimed at combating opioid and stimulant misuse in rural communities.

The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the Research Units (RUs), one of the two scientific components of the Pancreatic Cancer Detection Consortium (PCDC), to conduct research on early detection of pancreatic ductal adenocarcinoma (PDAC) and characterization of its precursor lesions to identify those patients who are at high risk of progression to cancer. The PCDC will continue to address one of the four research priorities identified in the National Cancer Institute's 2014 Scientific Framework for Pancreatic Ductal Adenocarcinoma. The PCDC will support research for the development and testing of new molecular and imaging biomarkers for detecting PDAC early and for identifying those patients at high risk of PDAC (because of genetic factors or presence of precursor lesions) who could be candidates for early intervention. The PCDC-RUs will consist of multi-disciplinary teams and will undertake studies to: identify and test biomarkers measurable in bodily fluids for early detection of PDAC and/or its precursor lesions; determine which pancreatic cysts are likely to progress to cancer; develop molecular- and/or imaging-based approaches for screening populations at high risk of PDAC; use machine learning and computational approaches towards biomarker discovery and/or validation; and conduct biomarker validation studies. The PCDC-RUs will also collect longitudinal biospecimens for building a biorepository. Each PCDC-RU is expected to participate in collaborative activities with other PCDC-RUs and share ideas, biospecimens and data within the Consortium. The other scientific component of the PCDC will be the Management and Data Coordination Unit (MDCU). The PCDC-MDCU will provide support toward study design, protocol development, statistical analysis, coordination, harmonization, data management and stewardship for the trans-PCDC collaborative projects, including biorepository building effort. The PCDC-MDCU will also supp

Grant Title: Generation III+ Small Modular Reactor Pathway to Deployment - This grant aims to accelerate the deployment of advanced small modular reactor technologies in the U.S. by providing funding to teams that demonstrate a clear plan for building and operating these reactors, thereby enhancing energy security and supporting clean energy goals.

This funding opportunity supports innovative research projects aimed at improving the understanding, prevention, and treatment of melanoma, particularly for military and Veteran populations.

The Bureau of International Narcotics and Law Enforcement Affairs (INL) of the U.S. Department of State announces an open competition for organizations to submit applications to carry out a project to engage in prosecutorial development and training in the Pacific Islands, particularly in the Freely Associated States (FAS) of the Federated States of Micronesia, Republic of Palau, and the Republic of the Marshall Islands. To this end, the FAS Prosecutorial Development (FASPro) project will work with relevant justice sector actors (e.g., ministries of justice, training institutes and law schools, bar associations, law firms, alternative courts, legislative bodies, regional and international organizations) to strengthen workforce pipelines in the legal sector in order to stimulate the development of prosecutorial offices in the FAS.

This funding opportunity provides financial support for universities, businesses, and organizations to develop and implement innovative technologies that convert carbon dioxide into useful products, helping to combat climate change and promote sustainability.

This funding opportunity provides financial support to U.S. academic and nonprofit institutions to implement innovative programs that enhance research rigor and transparency in neuroscience, fostering a culture of high-quality scientific practices.